PCOD
Polycystic ovarian disease
WE RUN SPECIAL CLINIC

PCOD

  • Complex interaction of genetic, metabolic, neurologic, endocrinal & environmental factors
  • It starts in adolescence
  • Sequelae continue even after menopause
  • Prevalence 4 -10%
  • Familial occurrence

PCOD
 Rotterdam criteria

  • Menstrual irregularity due to anovulation
    or oligoovulation
  • Hyperandrogenism- clinical / biochemical
  • Polycystic ovaries by USG- >12 follicles in each ovary,2- 9mm or ovarian volume >10mm
POLYCYSTIC OVARIES - USG

Pathophysiology of Polycystic Ovary Syndrome

  • LH Hypothesis
  • Insulin Hypothesis
  • Ovarian Hypothesis

CLINICAL FEATURES

  • Menstrual disturbances 80%
  • Hirsutism 70%
  • Obesity 60%
  • Insulin resistance 50%
  • Infertility 60%
Facial Hirsutism in PCOS
 
FERIMAN – GALLWAY SCORING

1980s – Association with PCOD

HAIR-AN Syndrome
Hyperandrogenism
Insulin resistance
Acanthosis nigricans

Acanthosis Nigricans

D/D

  • Congenital Adrenal Hyperplasia
  • Hyperprolactinemi
  • Thyroid disfunction
  • Cushing Syndrome
  • Hyperthecosis ovarii
  • Ovarian & Adrenal tumors
  • Hypogonadotropic Hypogonadism

INVESTIGATION

  • History & examination
  • LH:FSH, E2, Testosteron, SHBG, 17hydroxy progesteron, DHEAS, Prolactin, TFT, GTT & Insulin levels, Lipid Profile, USG, MRI
                          HIRSUTISM LAB EVALUATION

TREATMENT

  • Lifestyle modifications
  • Discuss the role of weight & body composition on PCOD
  • Weekly group meeting with parents
  • Aerobic exercises for 1hr/day
  • Nutrition & diet – most important
  • Cease smoking

TREATMENT MENSTRUAL REGULATION

  • Weight Reduction is most important
  • COC
         Yasmin / Yamini
         Diane35 / Dianette
  • Progesterons
         For protection of Endometrium

TREATMENT FOR HIRSUTISM (PCOD)

  • Weight Reduction
  • Mechanical & Cosmetic methods
  • COC
  • Anti-androgens Cyproteron Acetate
         Spironolactone
         Finasteride
  • Progesteron
  • GnRh

HYPERINSULINEMIA TREAMENT

  • Weight reduction
  • Life style modification
  • Insulin-sensitizers Metformin
        1500-2000 mg/day
        Rosiglitazone
        2-8mg/day

LONGTERM CONSEQUENCES Of Polycystic Ovarian Disease

  • Definite- Type II DM, Dyslipidemia, Endometrial Cancer
  • Possible- Obesity, Insulin resistance, Metabolic syndrome, Gall Bladder diseases, CVS disorders, Hypertension, Loss of self esteem, obstetric complication
  • Controversial – ovarian & breast cancer

PRACTICE POINT

  • Do not ignore your problems.
  • Consult doctor today